
Template post
Heading h2 – Lorem ipsum dolor sit amet Párrafo .h2 – Lorem ipsum dolor sit amet Heading h3 – Consetetur sadipscing elitr Párrafo .h3 –
Our Products
PreveCol®
Innovative blood-based test for colorectal cancer detection based on a biomarker signature.
DiagnoLung®
Innovative non-invasive signature for lung cancer diagnosis. It can be used for Lung Cancer diagnostics and as a tool for screening a high-risk population.
PancreaDix®
Innovative non-invasive signature in blood for the detection of pancreatic cancer (ductal adenocarcinoma (PDAC) and preneoplastic lesions).
Strategy
Amadix develops and commercializes breakthrough discoveries in cancer diagnosis improving survival and quality of life of patients. This will benefit the company, society and research as well as reducing cost for health authorities.
Team
Top level management team with extensive experience in cancer diagnostics. Resilience, determination and positivity are common characteristics of our team. Meet us here.
Scientific Board
We have established a Committee of Advisors with international profiles, and top-level scientists who advise the management team on strategy, business development and commercialization.
Board of Directors
Top level executives with extensive experience in the healthcare and diagnostics industry, corporate finance, and business development. Protecting shareholder’s interests.
Awards
AMADIX has received different awards in recognition of the high scientific value and technological quality of its projects and its feasibility, recognizing, at the same time, the great effort undertaken by the team.
Glossary
All about Cancer
Unmet Need
Current existing colorectal cancer screening methods, such as colonoscopy and fecal-based tests have limitations. Today, there is a significant clinical need that remains unmet for blood-based colorectal cancer screening that detects cancer early, accurately, and easily when it is in different stages. The solution developed by AMADIX –an innovative early colorectal cancer detection blood-based test– has high potential and has shown superior accuracy.
Exploring the Data
Amadix continues to go further, not only working at a molecular level but also exploring the infinite possibilities that clinical records and patient lifestyle data offer through the latest Artificial Intelligence (AI) and Advanced Data Analytical Tools, in order to identify new risk factors to develop predictive models which will help us anticipate hidden and underlying cancer risk factors and help improve the quality of life and survival of cancer patients.
Personalized and precision medicine
Specific information about the patient’s tumor is used to improve a cancer diagnosis, plan a therapy, determine whether a treatment is suitable for that specific individual or not, and give a prognosis. In personalized medicine, specific biomarkers are used for identifying a given disease or disorder.
News&Media
Latest News
Stay up-to-dated on breaking news from Amadix. Read the latest news and announcements.
Heading h2 – Lorem ipsum dolor sit amet Párrafo .h2 – Lorem ipsum dolor sit amet Heading h3 – Consetetur sadipscing elitr Párrafo .h3 –
Heading h2 – Lorem ipsum dolor sit amet Párrafo .h2 – Lorem ipsum dolor sit amet Heading h3 – Consetetur sadipscing elitr Párrafo .h3 –
Heading h2 – Lorem ipsum dolor sit amet Párrafo .h2 – Lorem ipsum dolor sit amet Heading h3 – Consetetur sadipscing elitr Párrafo .h3 –
Cookie | Duration | Description |
---|---|---|
_GRECAPTCHA | 5 months 27 days | This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks. |
cookielawinfo-checkbox-advertisement | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category . |
cookielawinfo-checkbox-functional | 1 year | The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category . |
cookielawinfo-checkbox-non-necessary | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Non-necessary" category . |
cookielawinfo-checkbox-others | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others". |
cookielawinfo-checkbox-performance | 1 year | Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance". |
elementor | never | This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time. |
viewed_cookie_policy | 1 year | The cookie is set by the GDPR Cookie Consent plugin to store whether or not the user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
_ga | 2 years | The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors. |
_ga_F40SS27Y9B | 2 years | This cookie is installed by Google Analytics. |